Linomide suppresses experimental autoimmune neuritis in Lewis rats by inhibiting myelin antigen-reactive T and B cell responses

Clinical and Experimental Immunology

Volumn 115, Issue 1, 1999, Pages 56-63

  Zhu, J ^a,e   Bai, X F ^f   Hedlund, G ^b   Bjork J ^c   Bakhiet, M ^f   Van Der Meide, P H ^d   Link, H ^f  

^a Pharmacia & Upjohn AB   (Sweden)

^b LUND UNIVERSITY   (Sweden)

^c PFIZER INC   (United States)

^d BIOMEDICAL PRIMATE RESEARCH CENTRE   (Netherlands)

^e KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^f NONE

Author keywords

Cytokine autoimmunity; Experimental autoimmune neuritis; Linomide; Myelin antigen

Indexed keywords

CYTOKINE; FREUND ADJUVANT; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; MESSENGER RNA; MYELIN; PNU 212616; ROQUINIMEX; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNE DISEASE; B LYMPHOCYTE; CYTOKINE PRODUCTION; EXPERIMENTAL MODEL; GUILLAIN BARRE SYNDROME; IN SITU HYBRIDIZATION; MALE; NEURITIS; NONHUMAN; PRIORITY JOURNAL; RAT; RNA ANALYSIS; SUBCUTANEOUS DRUG ADMINISTRATION; T LYMPHOCYTE;

EID: 0032917589     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1999.00768.x     Document Type: Article

References (36)

1. 1 Waksman BH, Adams RD. Allergic neuritis: an experimental disease of rabbits induced by the injection of peripheral nervous tissue and adjuvant. J Exp Med 1955; 102:213-25.
2. 2 Hartung HP, Pollard JD, Harvey GK, Toyka KV. Immunopathogenesis and treatment of the Guillain-Barré syndrome. Part I. Muscle and Nerve 1995; 18:137-53.
3. 3 McCombe PA. Autoimmune diseases. In: Pender MP, McCombe PA, eds. Autoimmune neurological diseases. Cambridge: Cambridge University Press, 1995:177-228.
4. 4 Linington C, Izumo S, Suzuki M, Uyemura K, Meyermann R, Wekerle H. A permanent rat T cell line that mediates experimental allergic neuritis in the Lewis rat in vivo. J Immunol 1984; 133: 1946-50.
5. 5 Linington C, Lassmann H, Ozawa K, Kosin S, Mongan L. Cell adhesion molecules of the immunoglobulin supergene family as tissue-specific autoantigens: induction of experimental allergic neuritis (EAN) by P0 protein-specific T cell lines. Eur J Immunol 1992; 22:1813-7.
6. 6 Zhu J, Link H, Mix E, Olsson T, Huang WX. Th1-like cell responses to peripheral nerve myelin components over the course of experimental allergic neuritis in Lewis rats. Acta Neurol Scand 1994; 90:19-25.
7. 7 Zhu J, Link H, Weerth S, Linington C, Mix E, Qiao J. The B cell repertoire in experimental allergic neuritis involves multiple myelin proteins and GM1. J Neurol Sci 1994; 125:132-7.
8. 8 Zhu J, Bai XF, Mix E, Link H. Experimental allergic neuritis: cytolysin mRNA expression is upregulated in lymph node cells during convalescence. J Neuroimmunol 1997; 78:108-16.
9. 9 Zhu J, Bai XF, Mix E, Link H. Cytokine dichotomy in the peripheral nervous tissues influence the outcome of experimental allergic neuritis: dynamics of mRNA expression for IL-1β, IL-6, IL-10, IL-12, tumor necrosis factor-α and TNF-β as well as cytolysin. Clin Immunol Immunopathol 1997; 84:85-94.
10. 10 Zhu J, Mix E, Link H. Cytokine production and the pathogenesis of experimental allergic neuritis and Guillain-Barré syndrome. J Neuroimmunol 1998; 84:40-52.
11. 11 Hughes RA, Atkinson P, Coates P, Hall S, Leibowitz S. Sural nerve biopsies in Guillain-Barré syndrome: axonal degeneration and macrophage-associated demyelination and absence of cytomegalovirus genome. Muscle Nerve 1992; 15:568-75.
12. 12 Dahle C, Ekerfelt C, Vrethem M, Samuelsson M, Ernerudh J. Th2-like responses to P0 and P2 peptides in the recovery phase of the Guillain-Barré syndrome. Acta Neurol Scand 1996; 94 (Suppl. 167):99 (Abstr.).
13. 13 Bai XF, Shi FD, Zhu J, Xiao BG, Link H. Linomide induced suppression of experimental autoimmune neuritis is associated with down-regulated macrophage functions. J Neuroimmunol 1997; 76:177-84.
14. 14 Karussis DM, Lehmann D, Slavin S et al. Inhibition of acute experimental autoimmune encephalomyelitis by the synthetic immunomodulator Linomide. Ann Neurol 1993; 34:654-60.
15. 15 Diab A, Levi M, Wahren B, Deng GM, Björk J, Hedlund G, Zhu J. Linomide suppresses acute experimental autoimmune encephalomyelitis in Lewis rats by counter-acting the imbalance of pro-inflammatory versus anti-inflammatory cytokines. J Neuroimmunol, 1998; 85:146-54.
16. 16 Zhu J, Diab A, Levi M, Wahren B, Björk J, Hedlund G, Mustafa M, Link H. Linomide suppresses chronic-relapsing experimental autoimmune encephalomyelitis in DA rats. J Neurol Sci, in press.
17. 17 Karussis DM, Lehmann D, Brenner T, Wirguin I, Mizrachi-Koll R, Sicssic C, Abramsky O. Immunomodulation of experimental autoimmune myasthenia gravis with linomide. J Neuroimmunol 1994; 55:187-93.
18. 18 Zhang GX, Yu LY, Shi FD, Xiao BG, Bjork J, Hedlund G, Link H. Linomide suppresses both Th1 and Th2 cytokine in experimental autoimmune myasthenia gravis. J Neuroimmunol 1997; 73:175-82.
19. 19 Norton WI, Poduslo SE. Myelination in rat nerve: method of myelin isolation. J Neurochem 1973; 21:749-57.
20. 20 Kadlubowski M, Hughes RAC, Gregson NA. Experimental allergic neuritis in the Lewis rat: characterization of the activity of peripheral myelin and its major basic protein P2. Brain Res 1980; 184:439-54.
21. 21 Milner P, Lovclidge CA, Taylor WA, Hughes RAC. P0 myelin protein produces experimental allergic neuritis in Lewis rats. J Neurol Sci 1987; 79:275-85.
22. 22 Olee T, Powers JM, Brostoff SW. A T cell epitope for experimental allergic neuritis. J. Neuroimmunol 1988; 19:167-73.
23. 23 Tarkowski A, Gunnarsson K, Nilsson LA, Lindholm L, Stalhandske T. Successful treatment of autoimmunity in MPL/lpr mice with LS-2616, a new immunomodulator. Arthritis Rheum 1986; 29:1405-9.
24. 24 Bjork J, Kleinau S. Paradoxical effects of LS-2616 (linomide) treatment in the type II collagen arthritis model in mice. Agents Actions 1989; 27:319-21.
25. 25 Karussis DM, Lehmann D, Slavin S, Kalland T, Vourka-Karussis U, Mizrachi-Koll R, Ovadia H, Abramsky O. Immunomodulation of autoimmunity by linomide. Isr J Med Sci 1995; 31:38-41.
26. 26 Strigård K, Holmdahl R, van der Meide P, Klareskog L, Olsson T. In vivo treatment of rats with monoclonal antibodies against gamma interferon: effects on experimental allergic neuritis. Acta Neurol Scand 1989; 80:201-7.
27. 27 Hartung HP, Schäfer B, van der Meide PH, Fierz W, Heininger K, Toyka KV. The role of interferon-gamma in the pathogenesis of experimental autoimmune disease of the peripheral nervous system. Ann Neurol 1990; 27:247-57.
28. 28 Schmidt B, Stoll G, van der Meide P, Jung S, Hartung HP. Transient cellular expression of gamma-interferon in myelin-induced and T-cell line-mediated experimental autoimmune neuritis. Brain 1992; 115:1633-46.
29. 29 Stoll G, Jung S, Jander S, van der Meide P, Hartung HP. Tumor necrosis factor-α in immune-mediated demyelination and Wallerian degeneration of the rat peripheral nervous system. J Neuroimmunol 1993; 45:175-82.
30. 30 Sharief MK, McLean B, Thompson EJ. Elevated serum levels of tumor necrosis factor-a in Guillain-Barré syndrome. Ann Neurol 1993; 33:591-6.
31. 31 Trinchieri G. Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu Rev Immunol 1995; 13:251-76.
32. 32 Schwartz RH. Advances in immunoregulation and immunotherapy. The Immunologist 1995; 3:5-6.
33. 33 Kiefer R, Funa K, Schweitzer T, Jung S, Bourde O, Toyka KV, Hartung HP. Transforming growth factor-β1 in experimental autoimmune neuritis. Cellular localization and time course. Am J Pathol 1996; 148:211-23.
34. 34 Howard M, O'Garra A. Biological properties of interleukin-10. Immunol Today 1992; 13:198-200.
35. 35 Bai XF, Zhu J, Zhang GX, Kaponides G, Höjeberg B, van der Meide PH, Link H. IL-10 suppresses experimental allergic neuritis, and down-regulates cytokine mRNA expression of Th1 and macrophage source. Clin Immunol Immunopathol. 1997; 2:117-26.
36. 36 Harvey GK, Pollard JD. Peripheral nervous system demyelination from systemic transfer of experimental allergic neuritis serum. J Neuroimmunol 1992; 41:159-66.